STOCK TITAN

ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

ALT5 Sigma (NASDAQ:ALTS) has appointed Ron Pitters to its Board of Directors. Pitters, currently serving as CAO of Axos Clearing and President of Axos Business Center Corp., brings over 20 years of experience in fintech, financial services, and emerging technologies. His global business management experience spans Asia, the Middle East, Europe, and the USA.

ALT5 Sigma, a fintech innovator providing blockchain-powered technologies, processed over US$1.2 billion in cryptocurrency transactions in 2023 through its platforms ALT5 Pay and ALT5 Prime. The company is also developing innovative solutions for the opioid crisis through its biotech division.

ALT5 Sigma (NASDAQ:ALTS) ha nominato Ron Pitters nel suo Consiglio di Amministrazione. Pitters, attualmente Chief Administrative Officer di Axos Clearing e Presidente di Axos Business Center Corp., porta con sé oltre 20 anni di esperienza nel fintech, nei servizi finanziari e nelle tecnologie emergenti. La sua esperienza nella gestione aziendale globale copre Asia, Medio Oriente, Europa e Stati Uniti.

ALT5 Sigma, un innovatore fintech che fornisce tecnologie basate su blockchain, ha elaborato oltre 1,2 miliardi di dollari USA in transazioni di criptovalute nel 2023 attraverso le sue piattaforme ALT5 Pay e ALT5 Prime. L'azienda sta anche sviluppando soluzioni innovative per la crisi degli oppiacei attraverso la sua divisione biotech.

ALT5 Sigma (NASDAQ:ALTS) ha nombrado a Ron Pitters en su Junta Directiva. Pitters, que actualmente se desempeña como CAO de Axos Clearing y Presidente de Axos Business Center Corp., aporta más de 20 años de experiencia en fintech, servicios financieros y tecnologías emergentes. Su experiencia en gestión empresarial global abarca Asia, Medio Oriente, Europa y Estados Unidos.

ALT5 Sigma, un innovador fintech que proporciona tecnologías basadas en blockchain, procesó más de 1,2 mil millones de dólares estadounidenses en transacciones de criptomonedas en 2023 a través de sus plataformas ALT5 Pay y ALT5 Prime. La compañía también está desarrollando soluciones innovadoras para la crisis de los opioides a través de su división biotecnológica.

ALT5 Sigma (NASDAQ:ALTS)는 Ron Pitters를 이사회의 일원으로 임명했습니다. Pitters는 현재 Axos Clearing의 최고 행정 책임자(CAO) 및 Axos Business Center Corp.의 사장으로 재직 중이며, 핀테크, 금융 서비스 및 신기술 분야에서 20년 이상의 경험을 보유하고 있습니다. 그의 글로벌 비즈니스 관리 경험은 아시아, 중동, 유럽 및 미국에 걸쳐 있습니다.

ALT5 Sigma는 블록체인 기반 기술을 제공하는 핀테크 혁신 기업으로, 2023년 ALT5 Pay 및 ALT5 Prime 플랫폼을 통해 미국 달러 12억 달러 이상의 암호화폐 거래를 처리했습니다. 이 회사는 또한 생명공학 부서를 통해 오피오이드 위기를 위한 혁신적인 솔루션을 개발하고 있습니다.

ALT5 Sigma (NASDAQ:ALTS) a nommé Ron Pitters au sein de son Conseil d'Administration. Pitters, actuellement directeur administratif d'Axos Clearing et président d'Axos Business Center Corp., apporte plus de 20 ans d'expérience dans le secteur du fintech, des services financiers et des technologies émergentes. Son expérience en gestion des affaires à l'échelle mondiale couvre l'Asie, le Moyen-Orient, l'Europe et les États-Unis.

ALT5 Sigma, un innovateur fintech fournissant des technologies basées sur la blockchain, a traité plus de 1,2 milliard de dollars américains en transactions de cryptomonnaies en 2023 via ses plateformes ALT5 Pay et ALT5 Prime. L'entreprise développe également des solutions innovantes pour la crise des opioïdes à travers sa division biotechnologique.

ALT5 Sigma (NASDAQ:ALTS) hat Ron Pitters in seinen Vorstand berufen. Pitters, der derzeit als CAO von Axos Clearing und Präsident von Axos Business Center Corp. tätig ist, bringt über 20 Jahre Erfahrung in den Bereichen Fintech, Finanzdienstleistungen und aufstrebende Technologien mit. Seine globale Geschäftserfahrung erstreckt sich über Asien, den Nahen Osten, Europa und die USA.

ALT5 Sigma, ein Fintech-Innovator, der Blockchain-basierte Technologien anbietet, hat 2023 über 1,2 Milliarden US-Dollar an Kryptowährungstransaktionen über seine Plattformen ALT5 Pay und ALT5 Prime verarbeitet. Das Unternehmen entwickelt auch innovative Lösungen zur Bekämpfung der Opioidkrise über seine Biotechnologietochter.

Positive
  • Processed over US$1.2 billion in cryptocurrency transactions in 2023
  • Addition of experienced fintech executive with global management expertise to the Board
  • Dual revenue streams through ALT5 Pay and ALT5 Prime platforms
  • Inclusion in Russell Microcap Index
Negative
  • None.

LAS VEGAS, NV / ACCESSWIRE / November 6, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, is pleased to announce the appointment of Mr. Ron Pitters to its Board of Directors.

"We are thrilled to welcome industry veteran, Ron Pitters, to our Board. With a unique blend of experience in both traditional finance and disruptive blockchain technologies, Ron brings invaluable insights. His proven track record, spanning from startups to multinational corporations, makes him a fantastic addition to our team," said ALT5 CEO, Peter Tassiopoulos.

Ron has a strong business and financial background focused on technology and management consulting. Mr. Pitters is currently the CAO of Axos Clearing LLC and President of Axos Business Center Corp., both subsidiaries of Axos Financial, Inc., a New York Stock Exchange listed company. He brings a wealth of experience to the Board of ALT5 Sigma.

For over 20 years, Ron has been an innovator and leader for global fintech, financial services, and emerging technologies, serving in a diverse range of senior leadership capacities in both technology and business. His expertise encompasses technology, capital markets, business innovation, product development, and business start-ups. Ron's background in managing global businesses in Asia, the Middle East, Europe, and the USA complements ALT5's global customer footprint.

Ron commented, "I have witnessed the organic growth of ALT5 over the years, and I am eager to support the Company and its management in building on that success as it establishes itself as a leader in the crypto ecosystem."

About ALT5

The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.

Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US$1.2 billion in cryptocurrency transactions in 2023.

ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.

Forward Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.

Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Contact Information

Investor Relations
ir@alt5sigma.com
1-800-400-2247

SOURCE: ALT 5 Sigma



View the original press release on accesswire.com

FAQ

How much in cryptocurrency transactions did ALT5 Sigma (ALTS) process in 2023?

ALT5 Sigma processed over US$1.2 billion in cryptocurrency transactions during 2023.

Who is the newest board member appointed to ALT5 Sigma (ALTS) in November 2024?

Ron Pitters, currently CAO of Axos Clearing and President of Axos Business Center Corp., was appointed to ALT5 Sigma's Board of Directors.

What are the main platforms offered by ALT5 Sigma (ALTS)?

ALT5 Sigma offers two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform.

ALT5 Sigma Corporation

NASDAQ:ALTS

ALTS Rankings

ALTS Latest News

ALTS Stock Data

31.84M
14.02M
4.85%
4.81%
1.81%
Software - Application
Pharmaceutical Preparations
Link
United States of America
LAS VEGAS